Dystrophin-deficient large animal models: translational research and exon skipping
- 15 August 2015
- journal article
- review article
- Vol. 7 (8), 1314-1331
Abstract
Duchenne muscular dystrophy (DMD) is an X-linked recessive genetic disorder caused by mutations in the dystrophin gene. Affecting approximately 1 in 3,600-9337 boys, DMD patients exhibit progressive muscle degeneration leading to fatality as a result of heart or respiratory failure. Despite the severity and prevalence of the disease, there is no cure available. While murine models have been successfully used in illustrating the mechanisms of DMD, their utility in DMD research is limited due to their mild disease phenotypes such as lack of severe skeletal muscle and cardiac symptoms. To address the discrepancy between the severity of disease displayed by murine models and human DMD patients, dystrophin-deficient dog models with a splice site mutation in intron 6 were established. Examples of these are Golden Retriever muscular dystrophy and beagle-based Canine X-linked muscular dystrophy. These large animal models are widely employed in therapeutic DMD research due to their close resemblance to the severity of human patient symptoms. Recently, genetically tailored porcine models of DMD with deleted exon 52 were developed by our group and others, and can potentially act as a new large animal model. While therapeutic outcomes derived from these large animal models can be more reliably extrapolated to DMD patients, a comprehensive understanding of these models is still needed. This paper will discuss recent progress and future directions of DMD studies with large animal models such as canine and porcine models.Keywords
This publication has 100 references indexed in Scilit:
- Factors influencing the efficiency of generating genetically engineered pigs by nuclear transfer: multi-factorial analysis of a large data setBMC Biotechnology, 2013
- Bortezomib (PS-341) Treatment Decreases Inflammation and Partially Rescues the Expression of the Dystrophin-Glycoprotein Complex in GRMD DogsPLOS ONE, 2013
- Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense deliveryProceedings of the National Academy of Sciences of the United States of America, 2012
- Long-term Restoration of Cardiac Dystrophin Expression in Golden Retriever Muscular Dystrophy Following rAAV6-mediated Exon SkippingMolecular Therapy, 2012
- Mammalian Models of Duchenne Muscular Dystrophy: Pathological Characteristics and Therapeutic ApplicationsJournal of Biomedicine and Biotechnology, 2011
- In-frame Dystrophin Following Exon 51-Skipping Improves Muscle Pathology and Function in the Exon 52–Deficient mdx MouseMolecular Therapy, 2010
- An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breedLaboratory Investigation, 2010
- Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogsJCI Insight, 2010
- Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohortHuman Mutation, 2009
- Serial cloning of pigs by somatic cell nuclear transfer: Restoration of phenotypic normality during serial cloningDevelopmental Dynamics, 2007